1. Home
  2. BBLG vs UGRO Comparison

BBLG vs UGRO Comparison

Compare BBLG & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BBLG

Bone Biologics Corp

N/A

Current Price

$1.30

Market Cap

2.6M

Sector

Health Care

ML Signal

N/A

Logo urban-gro Inc.

UGRO

urban-gro Inc.

HOLD

Current Price

$2.48

Market Cap

2.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBLG
UGRO
Founded
2004
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Industrial Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.6M
2.5M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
BBLG
UGRO
Price
$1.30
$2.48
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$75.00
AVG Volume (30 Days)
22.8K
212.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$40,008,850.00
Revenue This Year
N/A
$98.41
Revenue Next Year
N/A
$23.34
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.57
$0.11
52 Week High
$5.98
$4.50

Technical Indicators

Market Signals
Indicator
BBLG
UGRO
Relative Strength Index (RSI) 41.53 57.77
Support Level $1.11 $0.28
Resistance Level $1.88 $4.50
Average True Range (ATR) 0.08 0.39
MACD 0.01 -0.11
Stochastic Oscillator 50.91 14.32

Price Performance

Historical Comparison
BBLG
UGRO

About BBLG Bone Biologics Corp

Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.

About UGRO urban-gro Inc.

Urban-gro Inc operated as an integrated professional services and design-build firm offering architectural, engineering, and construction management solutions to the CEA, industrial, healthcare, and other commercial sectors. The company generated revenue by billing employees time on client projects and provided architectural, engineering, systems procurement and integration, and construction design-build solutions with a single point of accountability. For CEA clients, it developed indoor cultivation facilities for specialty crops, including cannabis and produce such as leafy greens, vegetables, herbs, and berries. Its segments included Equipment Systems (commercial horticulture equipment), Services (design-build services), and Construction Design-Build (general contracting).

Share on Social Networks: